Phenobarbital is widely used in the treatment of children with febrile seizures, although there is concern about possible behavioral and cognitive side effects. In 217 children between 8 and 36 months of age who had had at least one febrile seizure and were at heightened risk of further seizures, we compared the intelligence quotients (IQs) of a group randomly assigned to daily doses of phenobarbital (4 to 5 mg per kilogram of body weight per day) with the IQs of a group randomly assigned to placebo. After two years, the mean IQ was 7.03 [corrected] points lower in the group assigned to phenobarbital than in the placebo group (95 percent confidence interval, -11.52 to -2.5, P = 0.0068 [corrected]). Six months later, after the medication had been tapered and discontinued, the mean IQ was 5.2 points lower in the group assigned to phenobarbital (95 percent confidence interval, -10.5 to 0.04, P = 0.052). The proportion of children remaining free of subsequent seizures did not differ significantly between the treatment groups. We conclude that phenobarbital depresses cognitive performance in children treated for febrile seizures and that this disadvantage, which may outlast the administration of the drug by several months, is not offset by the benefit of seizure prevention.
Source Information
University of Washington School of Medicine, Seattle.
This article has been cited by other articles:
Steering Committee on Quality Improvement and Mana,
(2008). Febrile Seizures: Clinical Practice Guideline for the Long-term Management of the Child With Simple Febrile Seizures. Pediatrics
121: 1281-1286
[Abstract][Full Text]
Gravel, J., Opatrny, L., Shapiro, S.
(2007). The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?. Clin Trials
4: 350-356
[Abstract]
Banu, S. H, Jahan, M., Koli, U. K., Ferdousi, S., Khan, N. Z, Neville, B.
(2007). Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. BMJ
334: 1207-1207
[Abstract][Full Text]
Guillet, R., Kwon, J.
(2007). Seizure Recurrence and Developmental Disabilities After Neonatal Seizures: Outcomes Are Unrelated to Use of Phenobarbital Prophylaxis. J Child Neurol
22: 389-395
[Abstract]
Koh, S., Chung, H., Hongjing Xia, , Mahadevia, A., Song, Y.
(2005). Environmental Enrichment Reverses the Impaired Exploratory Behavior and Altered Gene Expression Induced by Early-Life Seizures. J Child Neurol
20: 796-802
[Abstract]
Sankar, R.
(2004). Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues. Neurology
63: S30-S39
[Abstract][Full Text]
Bourgeois, B. F. D.
(2004). Determining the Effects of Antiepileptic Drugs on Cognitive Function in Pediatric Patients With Epilepsy. J Child Neurol
19: S15-S24
[Abstract]
Loring, D. W., Meador, K. J.
(2004). Cognitive side effects of antiepileptic drugs in children. Neurology
62: 872-877
[Abstract][Full Text]
Bourgeois, B. F. D.
(2004). Determining the Effects of Antiepileptic Drugs on Cognitive Function in Pediatric Patients With Epilepsy. J Child Neurol
19: S15-S24
[Abstract]
Bittigau, P., Sifringer, M., Genz, K., Reith, E., Pospischil, D., Govindarajalu, S., Dzietko, M., Pesditschek, S., Mai, I., Dikranian, K., Olney, J. W., Ikonomidou, C.
(2002). Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl. Acad. Sci. USA
99: 15089-15094
[Abstract][Full Text]
Bourgeois, B. F.D.
(2002). Differential Cognitive Effects of Antiepileptic Drugs. J Child Neurol
17: 2S28-2S33
[Abstract]
Shinnar, S., Glauser, T. A.
(2002). Febrile Seizures. J Child Neurol
17: S44-S52
[Abstract]
Vitiello, B.
(2001). Psychopharmacology for Young Children: Clinical Needs and Research Opportunities. Pediatrics
108: 983-989
[Abstract][Full Text]
Agrawal, A. K., Shapiro, B. H.
(2000). Latent Overexpression of Hepatic CYP2C7 in Adult Male and Female Rats Neonatally Exposed to Phenobarbital: A Developmental Profile of Gender-Dependent P450s. J. Pharmacol. Exp. Ther.
293: 1027-1033
[Abstract][Full Text]
Lerman-Sagie, T., Lerman, P.
(1999). Phenobarbital Still Has a Role in Epilepsy Treatment. J Child Neurol
14: 820-821
[Abstract]
Painter, M. J., Scher, M. S., Stein, A. D., Armatti, S., Wang, Z., Gardiner, J. C., Paneth, N., Minnigh, B., Alvin, J.
(1999). Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures. NEJM
341: 485-489
[Abstract][Full Text]
Sulzbacher, S., Farwell, J. R., Temkin, N., Lu, A. S., Hirtz, D. G.
(1999). Late Cognitive Effects of Early Treatment with Phenobarbital. CLIN PEDIATR
38: 387-394
[Abstract]
Baumann, R. J.
(1999). Technical Report: Treatment of the Child With Simple Febrile Seizures. Pediatrics
103: 86e-86
[Abstract][Full Text]
Carter, R. B., Wood, P. L., Wieland, S., Hawkinson, J. E., Belelli, D., Lambert, J. J., White, H. S., Wolf, H. H., Mirsadeghi, S., Tahir, S. H., Bolger, M. B., Lan, N. C., Gee, K. W.
(1997). Characterization of the Anticonvulsant Properties of Ganaxolone (CCD 1042; 3alpha -Hydroxy-3beta -methyl-5alpha -pregnan-20-one), a Selective, High-Affinity, Steroid Modulator of the gamma -Aminobutyric AcidA Receptor. J. Pharmacol. Exp. Ther.
280: 1284-1295
[Abstract][Full Text]
Kuturec, M., Emoto, S.E., Sofijanov, N., Dukovski, M., Duma, F., Ellenberg, J.H., Hirtz, D.G., Nelson, K.B.
(1997). Febrile Seizures: Is the EEG a Useful Predictor of Recurrences?. CLIN PEDIATR
36: 31-36
[Abstract]
Hirtz, D. G.
(1997). Febrile Seizures. Pediatr. Rev.
18: 5-9
[Full Text]
Sylvester, C. E., Marchlewski, A., Manaligod, J. M.
(1994). Primidone or Phenobarbital Use Complicating Disruptive Behavior Disorders. CLIN PEDIATR
33: 252-253
[Abstract]
Simon, H. B.
(1993). Hyperthermia. NEJM
329: 483-487
[Full Text]
Rosman, N. P., Colton, T., Labazzo, J., Gilbert, P. L., Gardella, N. B., Kaye, E. M., Van Bennekom, C., Winter, M. R.
(1993). A Controlled Trial of Diazepam Administered during Febrile Illnesses to Prevent Recurrence of Febrile Seizures. NEJM
329: 79-84
[Abstract][Full Text]
Previous
